March 2021 - Page 3 of 43

TuesdayMar 30, 2021 11:38 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Unveils New MyoCorrect Orofacial Myofunctional Therapy Service

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), has announced a new service called MyoCorrect. The exclusive training provides therapists with access to orofacial myofunctional therapy (“OMT”) via telemedicine technology using the company’s Vivos System. Vivos anticipates this new service will provide increased revenue through With this new training, Vivos expects to see additional revenue through increased cases and fees. The company expects its MyoCorrect service will become an effective treatment of OSA, thereby giving Vivos an additional competitive advantage in the OSA treatment…

TuesdayMar 30, 2021 11:14 am

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Featured in Bell2Bell Podcast

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. Uranium Energy’s CEO and President, Amir Adnani, joined the latest episode to discuss the company’s recent news and milestones, which include strengthening of its balance sheet that totals close to $95 million in cash and equity holdings, including approximately $61 million in cash. Adnani also discussed the company’s establishment of a physical uranium holding initiative. “This has really both resonated with the market and,…

TuesdayMar 30, 2021 10:55 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leverages Multi-Omic Approach to New Drug Discovery

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery. While the pharmaceutical industry has historically invested heavily in genomics and big data, hoping to better understand individual patient’s genomes and deliver targeted therapeutics, the use of genomics alone has proven disappointing. Predictive Oncology is confident that a multi-omic approach offers a much greater ability for success. The company is a leader in this area where few comprehensive, multi-omic datasets exist, especially in cancer, and such data is difficult to quickly access, as well as costly and…

TuesdayMar 30, 2021 10:43 am

Healthy Extracts Inc. (HYEX) Leverages the Plant-Based Industry Boon For Continued Revenue Growth

Healthy Extracts Inc. recently declared its 2020 Q4 results showing an exponential revenue increase of 71% from last year The company’s proprietary Fuel4Thought(TM) Brain Booster product is undergoing clinical testing, and is slated for release in Q2 Healthy Extracts, Inc.(TM) officially changed its name from Grey Cloak Tech Inc. on March 1, 2020 Healthy Extracts (OTCQB: HYEX), is a leading researcher and manufacturer of plant-based formulations whose objective is to offer a better lifestyle through superior heart and brain health technology. The company is focused on strengthening and expanding its market reach through its science-based wholly-owned subsidiaries BergaMet North America (BergaMet…

TuesdayMar 30, 2021 10:32 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Featured in Latest Episode of Bell2Bell Podcast

Green Hygienics Holdings (OTCQB: GRYN) was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. GRYN’s CEO, Ron Loudoun, joined the latest episode, where he highlighted last year’s milestones in establishing GRYN at the company’s 824-acre farm with 400,000 square feet of greenhouse. “We cultivated 120 acres last year and it turned out beautifully. We’ve proven out our ability to grow premium product there,” Loudoun said, discussing the property’s idyllic environment for the hemp plant with nutrient-rich soil, altitude that enables night-time cooling for better growth and an…

TuesdayMar 30, 2021 10:32 am

QualityStocksNewsBreaks – Rritual Superfoods Inc. (CSE: RSF) Full Product Line to Launch in Rite Aid Retail Locations, on e-Commerce Site

Rritual Superfoods (CSE: RSF, RSF.WT), a functional superfood company that creates plant-based elixirs that support immunity, focus and relaxation, has announced that its products will be available in Rite Aid retail stores located across the United States; beginning in Q2 and Q3 2021, an estimated 1,000 Rite Aid locations, along with the Rite Aid e-commerce site, will offer Rritual superfoods. Rritual has a strategic development plan targeting major retailers in order to gain market share and category-defining leadership, and the distribution agreement with Rite Aid, the third largest drugstore chain in the country, aligns with this focus. Rite Aid will…

TuesdayMar 30, 2021 9:58 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Appoints New Management Positions, Focused on Development and Clinical Operations

Cybin (NEO: CYBN) (OTCQB: CLXPF) announced changes in senior management positions. Cybin US Holdings Inc.’s new chief clinical officer will be Alexander Belser, PhD and its new chief operating officer will be Aaron Bartlone. In addition, co-founder and former COO Paul Glavine has been named chief growth officer and co-founder of Cybin Inc., while former SVP of business development John Kanakis will become chief business officer. The changes are effective immediately. An accomplished biopharmaceutical executive with a proven track record across numerous therapeutic and functional areas, Bartlone has extensive experience with quality assurance, regulatory affairs, product development, compliance and commercial…

TuesdayMar 30, 2021 9:52 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Quarter, FY 2020 Financial Report

Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial results for fourth quarter and fiscal year for the period ended Dec. 31, 2020. The report also included key operational highlights. Financial numbers noted that the company’s revenues for the quarter increased 17.1% to $2 million, compared to revenue of $1.7 million in the same quarter last year; gross profit for Q4 decreased, primarily because of higher costs associated with Trxade Prime transactions and a write down…

TuesdayMar 30, 2021 9:15 am

QualityStocksNewsBreaks – SRAX (NASDAQ: SRAX) Releases Q4 Numbers, Operational Highlights

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (”SaaS”) platform, has reported its fourth-quarter 2020 numbers; the report also noted company highlights for the quarter and full year. According to the announcement, the company saw Q4 revenue of $4.5 million, an increase of 316% year over year and a 74% increase quarter over quarter. The company’s full-year revenue guidance increase from $17–$18 million to $23–$25 million. SRAX noted that its Sequire SaaS had seen eight quarters of growth, with bookings of $4.8 million for the fourth quarter and…

MondayMar 29, 2021 3:21 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Receives ‘Buy’ Rating from H.C. Wainwright & Co.

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, recently announced the close an offering of 10 million shares, resulting in an estimated $30.5 million for the company. According to the announcement, the company plans to use the funds to support its physical uranium purchase initiative as well as for general corporate and working capital requirements. Based on the company’s announcement, H.C. Wainwright & Co. released a target price revision; the report noted a price of $2.65 and a buy rating. “While the company remains focused on developing its low-cost, in-situ recovery (‘ISR’) mining capabilities, management has…

Site Search

Company Search

Month: March 2021